A journal author argues that the current health system puts too much emphasis on patient safety when our resources should instead be aimed at the programs and activities that will result in the greatest overall improvement in patient health.
New guidelines and the continuous modification of current policies will be needed in order to establish and maintain an appropriate professional relationship between physicians and pharmaceutical companies.